- Home
- SGMT vs EAF Comparison
SGMT vs EAF Comparison
Compare SGMT & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SGMT | EAF |
|---|---|---|
| Founded | 2006 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 183.6M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SGMT | EAF |
|---|---|---|
| Price | $6.95 | $7.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $26.13 | $11.75 |
| AVG Volume (30 Days) | ★ 781.4K | 244.5K |
| Earning Date | 05-14-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,000,000.00 | ★ $504,134,000.00 |
| Revenue This Year | N/A | $4.25 |
| Revenue Next Year | N/A | $12.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.50 | $0.93 |
| 52 Week High | $11.41 | $20.32 |
Technical Indicators
Market Signals| Indicator | SGMT | EAF |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 37.82 |
| Support Level | $6.26 | $6.12 |
| Resistance Level | $7.20 | $7.73 |
| Average True Range (ATR) | 0.33 | 0.62 |
| MACD | 0.05 | -0.16 |
| Stochastic Oscillator | 76.82 | 19.84 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products used as raw material in the production of graphite electrodes.